DarioHealth Announces $14.3 Million Private Placement
Newly designated convertible preferred stock priced at the market under Nasdaq rules with significant participation by select members of leadership, the Board and existing investors Company also announces refinancing of $25 million borrowed funds, saving approximately $6 million in annual amortization payments Proforma cash balance as of the end of Q1 inclusive of the private placement funds and the refinanced loan is $60M , /PRNewswire/ — DarioHealth Corp.
Read More from the Global Wellness News ™